In a recent Select Science Editorial Article, Dr. Peter Betz Wolff, of the Analytical Development department at AGC Biologics, who works to implement and develop a range of cell-based assays to meet specific client needs shares how his team recommend the use of assay-ready cells to provide the valuable biologically relevant data required for robust pharmaceutical development.
The article also deals with how assay-ready cells take a lot of the maintenance out of a project and that the biggest advantage with cell-based systems is that they are a biologically relevant system.
